Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
TP53 deficiency permits chromosome abnormalities and karyotype heterogeneity in acute myeloid leukemia
Ist Teil von
Leukemia, 2019-11, Vol.33 (11), p.2619-2627
Ort / Verlag
London: Nature Publishing Group UK
Erscheinungsjahr
2019
Quelle
MEDLINE
Beschreibungen/Notizen
Abnormal karyotypes are common in cancer cells and frequently observed in acute myeloid leukemia (AML), in which complex karyotype aberrations are associated with poor prognosis. How exactly abnormal karyotypes arise and are propagated in AML is unclear.
TP53
mutations and deletions are frequent in complex karyotype AML, suggesting a role of
TP53
alterations in the development of chromosome abnormalities. Here, we generated isogenic
TP53
-knockout versions of the euploid AML cell line EEB to investigate the impact of
TP53
on karyotype stability. We show that chromosome abnormalities spontaneously arise in TP53-deficient cells. Numerical aneuploidy could, to some extent, be propagated in a TP53-proficient setting, indicating that it does not necessarily trigger TP53 activation. In contrast, tolerance to structural chromosome aberrations was almost entirely restricted to
TP53
-knockout clones, all of which were able to continue proliferation in the presence of damaged DNA. Mechanistically, as a source of chromosome aberrations, limited numerical but not structural chromosomal instability was tolerated by
TP53
-wildtype cells. In contrast, structural instability was found only in
TP53
-knockout cells. Together, in myeloid cells
TP53
loss allows for the development of complex karyotype aberrations and karyotype heterogeneity by perpetuation of chromosome segregation errors.